Citation: Pg. Rose et al., PROLONGED ORAL ETOPOSIDE AS 2ND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUPSTUDY, Journal of clinical oncology, 16(2), 1998, pp. 405-410
Authors:
MUGGIA FM
BLESSING JA
HOMESLEY HD
SOROSKY J
Citation: Fm. Muggia et al., TOMUDEX (ZD1694, NSC639186) IN PLATINUM-PRETREATED RECURRENT EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY BY THE GYNECOLOGIC-ONCOLOGY-GROUP, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 68-70
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH ENDOMETRIAL CANCER - AGYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(4), 1998, pp. 406-407
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(3), 1998, pp. 306-307
Authors:
ASBURY R
BLESSING JA
BULLER R
MALFETANO JH
WALKER J
SEVIN BU
Citation: R. Asbury et al., AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(2), 1998, pp. 145-146
Authors:
LOOK KY
BLESSING JA
LEVENBACK C
KOHLER M
CHAFE W
ROMAN LD
Citation: Ky. Look et al., A PHASE-II TRIAL OF CPT-11 IN RECURRENT SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology (Print), 70(3), 1998, pp. 334-338
Citation: Pg. Rose et al., PROLONGED ORAL ETOPOSIDE IN RECURRENT OR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology (Print), 70(2), 1998, pp. 263-266
Citation: Pg. Rose et al., PROLONGED ORAL ETOPOSIDE IN RECURRENT OR ADVANCED LEIOMYOSARCOMA OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology (Print), 70(2), 1998, pp. 267-271
Authors:
MARKMAN M
BLESSING JA
MOORE D
BALL H
LENTZ SS
Citation: M. Markman et al., ALTRETAMINE (HEXAMETHYLMELAMINE) IN PLATINUM-RESISTANT AND PLATINUM-REFRACTORY OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP PHASE-II TRIAL, Gynecologic oncology (Print), 69(3), 1998, pp. 226-229
Citation: A. Manetta et al., EVALUATION OF CISPLATIN AND CYCLOSPORINE-A IN RECURRENT PLATINUM-RESISTANT OVARIAN-CANCER - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP, Gynecologic oncology, 68(1), 1998, pp. 45-46
Authors:
OMURA GA
BLESSING JA
VACCARELLO L
BERMAN ML
CLARKEPEARSON DL
MUTCH DG
ANDERSON B
Citation: Ga. Omura et al., RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN PLUS MITOLACTOL VERSUSCISPLATIN PLUS IFOSFAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 165-171
Authors:
ASBURY R
BLESSING JA
LOOK KY
BULLER R
LUCCI JA
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMONAFIDE IN PATIENTS WITH NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 20(6), 1997, pp. 626-627
Citation: S. Lincoln et al., PHASE-II TRIAL OF PIROXANTRONE IN ADVANCED SQUAMOUS-CELL CARCINOMA OFTHE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 20(1), 1997, pp. 84-85
Authors:
LOOK KY
BLESSING JA
VALEA FA
MCGEHEE R
MANETTA A
WEBSTER KD
ANDERSEN WA
Citation: Ky. Look et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN RECURRENT ADENOCARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 67(3), 1997, pp. 255-258
Authors:
MCGUIRE WP
BLESSING JA
MOORE D
LENTZ SS
PHOTOPULOS G
Citation: Wp. Mcguire et al., PACLITAXEL HAS MODERATE ACTIVITY IN SQUAMOUS CERVIX CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 14(3), 1996, pp. 792-795
Citation: Ky. Look et al., A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(5), 1996, pp. 439-441
Citation: R. Asbury et al., A PHASE-II TRIAL OF AMINOTHIADIAZOLE IN PATIENTS WITH MIXED MESODERMAL TUMORS OF THE UTERINE CORPUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(4), 1996, pp. 400-402
Authors:
MALFETANO JH
BLESSING JA
HOMESLEY HD
LOOK KY
MCGEHEE R
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF DIDEMNIN-B (NSC-NUMBER-335319) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX A GYNECOLOGIC-ONCOLOGY-GROUP STUDY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(2), 1996, pp. 184-186
Authors:
LOOK KY
BLESSING JA
ADELSON MD
MORRIS M
BOOKMAN MA
Citation: Ky. Look et al., A PHASE-II TRIAL OF MERBARONE (NSC-336628) IN THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(1), 1996, pp. 7-9
Authors:
SUTTON GP
BLESSING JA
DEMARS LR
MOORE D
BURKE TW
GRENDYS EC
Citation: Gp. Sutton et al., A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP TRIAL OF IFOSFAMIDE AND MESNA IN ADVANCED OR RECURRENT ADENOCARCINOMA OF THE ENDOMETRIUM, Gynecologic oncology, 63(1), 1996, pp. 25-27
Authors:
ROSE PG
BLESSING JA
LEWANDOWSKI GS
CREASMAN WT
WEBSTER KD
Citation: Pg. Rose et al., A PHASE-II TRIAL OF PROLONGED ORAL ETOPOSIDE (VP-16) AS 2ND-LINE THERAPY FOR ADVANCED AND RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 63(1), 1996, pp. 101-104
Authors:
THIGPEN T
BLESSING JA
YORDAN E
VALEA F
VACCARELLO L
Citation: T. Thigpen et al., PHASE-II TRIAL OF ETOPOSIDE IN LEIOMYOSARCOMA OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 63(1), 1996, pp. 120-122
Citation: G. Sutton et al., IFOSFAMIDE AND DOXORUBICIN IN THE TREATMENT OF ADVANCED LEIOMYOSARCOMAS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 62(2), 1996, pp. 226-229
Citation: Hg. Ball et al., A PHASE-II TRIAL OF PACLITAXEL IN PATIENTS WITH ADVANCED OR RECURRENTADENOCARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 62(2), 1996, pp. 278-281
Citation: Pg. Rose et al., PHASE-II EVALUATION OF ALTRETAMINE FOR ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 62(1), 1996, pp. 100-102